Heart Disease Clinical Trials in Baltimore

Showing 381-400 of 583 trials

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651

This is a Phase 4, multicenter, open-label (blinded Pharmacodynamic PD results), randomized, 3-arm, parallel-design study of subjects with stable Coronary Artery Disease CAD. This study will compare the PD effect of prasugrel 10 mg QD (once-daily) maintenance dose with ticagrelor 90 mg BID (twice daily) maintenance dose in subjects with stable CAD who have previously received ticagrelor loading does (LD) and maintenance dose (MD)..

Coronary Artery Disease

Daiichi Sankyo110 participantsStarted Mar 2012

Jacksonville, Florida, United States • Miami, Florida, United States • Port Orange, Florida, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

NCT00934037

The purpose of this study is to evaluate the diagnostic accuracy of multi-detector computed tomography using 320 detectors for identifying the combination of coronary artery stenosis ≥ 50% and a corresponding myocardium perfusion defect in a patient with suspected coronary artery disease compared with conventional coronary angiography and single photon emission computed tomography myocardium perfusion imaging.

Arterial Occlusive DiseasesCoronary DiseaseHeart Diseases+5 more

Johns Hopkins University444 participantsStarted Dec 2009

Baltimore, Maryland, United States • Bethesda, Maryland, United States • Boston, Massachusetts, United States +13 more locations

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Heart Disease Trials in Other Cities

Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction

Initial Study of Fenoterol as a Treatment for Heart Failure

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Vascular Inflammation in Psoriasis - Extension Study

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease

CANVAS - CANagliflozin cardioVascular Assessment Study

An Assessment of the Glider Balloon in Complex Lesions

Sapphire II PRO US Clinical Study

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

Global Non-interventional Heart Failure Disease Registry

Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Other Conditions in Baltimore